Calquence is under clinical development by AstraZeneca and currently in Phase II for Graft Versus Host Disease (GVHD).

Calquence is under clinical development by AstraZeneca and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

CURE® spoke with an expert about follicular lymphoma, a disease that is still considered incurable. There have been a number of advancements in the treatment of follicular lymphoma in 2024.

More than 400 people have been affected by an undiagnosed illness that some are calling "Disease X," in the Democratic Republic of the Congo (DRC)—specifically, Panzi health zone, Kwango ...

A mysterious illness, which the Africa Centers for Disease Control and Prevention is calling "disease X," has killed at least 31 people — mostly children — in the remote Panzi region of the ...

‘Disease X’ Outbreak Widens as UN Sends Health Team to Congo The number of reported cases of flu-like illness rises to 416 Headache, cough, runny nose and body aches are among symptoms ...

Department of Hepatobiliary Surgery of General Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Preface and importance: Burkitt’s lymphoma ...

For the follicular lymphoma trial, Alderuccio and his colleagues enrolled patients whose cancer had not only relapsed or failed to respond to treatment but also showed a high disease burden or had ...

Alzheimer’s disease is a neurological condition that causes a decline in thinking skills and memory. There is currently no cure, but there are ways to support a person with medication and other ...

An undiagnosed 'Disease X' is spreading in a remote region of the Democratic Republic of Congo. The WHO and AfricaCDC have sent scientists to discover what it is. Can it be treated? https://p.dw ...

A "mystery disease" recently struck the south-western corner of the Democratic Republic of Congo (DRC), killing between 67 and 143 people over two weeks. The disease was reported to cause flu-like ...